Diagnostic Usefulness of SP-D, CCL2/MCP-1, and IL-18 in Assessing Respiratory Function and Risk of Pulmonary Fibrosis in COVID-19 Patients
Bogdan Cylwik, Kacper Gan, Marcin Kazberuk, Ewa Gruszewska, Anatol Panasiuk, Magdalena Sienkiewicz, Malgorzata Wojtkowska, Lech Chrostek · 2026
Read Diagnostic Usefulness of SP-D, CCL2/MCP-1, and IL-18 in Assessing Respiratory Function and Risk of Pulmonary Fibrosis in COVID-19 Patients by Bogdan Cylwik, Kacper Gan, Marcin Kazberuk, Ewa Gruszewska, Anatol Panasiuk, Magdalena Sienkiewicz, Malgorzata Wojtkowska, Lech Chrostek (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13206226.txt.
Description
Bogdan Cylwik and seven co-authors test whether three blood markers can flag lung harm and scar risk early in COVID-19. The markers are a lung protein and two signals tied to swelling and scar growth. Their 2026 study drew blood from 87 patients and 45 healthy people for contrast.
All three markers ran higher in patients than in healthy controls. One marker tracked how severe the illness was, and it rose most in the sickest group. The other two linked to oxygen levels and to signs of lung scar growth. The authors say the trio may help grade lung harm at the start of illness. Two of them may also warn of later lung scarring.
Catalog record
| CREATOR | Bogdan Cylwik, Kacper Gan, Marcin Kazberuk, Ewa Gruszewska, Anatol Panasiuk, Magdalena Sienkiewicz, Malgorzata Wojtkowska, Lech Chrostek |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |